Excedrin Tablet, Film Coated
NDC 0067-2003
Product Information
Excedrin (acetaminophen, aspirin (nsaid), caffeine) is a OTC MONOGRAPH DRUG-approved product labeled by Haleon Us Holdings Llc. This medication is typically used as a anti-inflammatory agents. It is supplied as a white tablet, film coated for oral administration. This product entry covers the primary NDC 0067-2003 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
E
ES
Code Structure Chart
Product Details
What is NDC 0067-2003?
What are the uses of this product?
What are Active Ingredients of this product?
- ACETAMINOPHEN 250 mg/1 - Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
- ASPIRIN 250 mg/1 - The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
- CAFFEINE 65 mg/1 - A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
- ASPIRIN (UNII: R16CO5Y76E)
- ASPIRIN (UNII: R16CO5Y76E) (Active Moiety)
- CAFFEINE (UNII: 3G6A5W338E)
- CAFFEINE (UNII: 3G6A5W338E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZOIC ACID (UNII: 8SKN0B0MIM)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- LIGHT MINERAL OIL (UNII: N6K5787QVP)
- LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 2165RE0K14)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SORBITAN MONOLAURATE (UNII: 6W9PS8B71J)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- STARCH, CORN (UNII: O8232NY3SJ)
- CROSPOVIDONE, UNSPECIFIED (UNII: 2S7830E561)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 209468 - EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet
- RxCUI: 209468 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]
- RxCUI: 209468 - APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin]
- RxCUI: 209468 - Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
- RxCUI: 209468 - Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
Which are the Pharmacologic Classes of this product?
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
* Please review the full disclaimer at the bottom of this page.